Ifp Advisors, Inc Genprex, Inc. Transaction History

Ifp Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 06, 2022	BUY	$1.28 - $2.31 $5,120 - $9,240	4,000 New	4,000 $43,000
Q2 2022 Aug 12, 2022	SELL	$1.28 - $2.31 $5,120 - $9,240	-4,000 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$1.82 - $3.5 $7,280 - $14,000	4,000 New	4,000 $9,000
Q3 2019 Nov 07, 2019	SELL	$0.8 - $1.18 $15,500 - $22,862	-19,375 Closed	0 $0
Q1 2016 Jun 03, 2019	BUY	N/A	19,375	19,375 $30,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $76.8M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.